 CAMBRIDGE, Mass., March 10, 2021 PRNewswire -- Blueprint Medicines Corporation NASDAQ: BPMC today announced plans to present new data for multiple research- and clinical-stage programs across the companys precision oncology and hematology portfolio at the American Association for Cancer Research AACR Annual Meeting 2021. 